Janux Therapeutics Inc Logo

Janux Therapeutics Inc (JANX): Eigentümerstruktur

Takani Score ?
33.8

Preis (11.09.2026)52W Hoch52W Tief
17,1 US Dollar35,34 US Dollar12,12 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
36,235 US Dollar111100
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
61.136.77312,78,7

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Janux Therapeutics Inc
Mitarbeiter 113
Handelsplatz NASDAQ
Ticker Symbol JANX
IPO Datum 2021-06-11
Adresse 10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130

Unternehmensführung

RangNamePosition
1Dr. David Alan Campbell Ph.D.President, Co-Founder, CEO & Director
2Dr. Thomas Diraimondo Ph.D.Chief Scientific Officer
3Ms. Janeen DoyleChief Corporate & Business Development Officer
4Mr. Matt WhitmireVice President of Finance
5Ms. Maria DobekVice President of Accounting
6Mr. Charles M. WinterChief Technical Officer
7Mr. James PenningtonGeneral Counsel & Corporate Secretary
8Ms. Mandie Forman-SklanskyHead of Human Resources

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1RA Capital Management, LLC18,30%0,19 Mrd. USD
2BlackRock Inc8,89%0,09 Mrd. USD
3HHG PLC6,86%0,07 Mrd. USD
4Prosight Management, LP6,22%0,07 Mrd. USD
5FMR Inc4,15%0,04 Mrd. USD
6State Street Corp4,03%0,04 Mrd. USD
7Federated Hermes Inc3,85%0,04 Mrd. USD
8Vanguard Capital Management, LLC2,96%0,03 Mrd. USD
9TCG Crossover Management, LLC2,93%0,03 Mrd. USD
10Alyeska Investment Group, L.P.2,62%0,03 Mrd. USD
11Wellington Management Company LLP2,47%0,03 Mrd. USD
12Vanguard Portfolio Management, LLC2,11%0,02 Mrd. USD
13Two Sigma Investments LLC1,97%0,02 Mrd. USD
14Citadel Advisors Llc1,96%0,02 Mrd. USD
15Point72 Asset Management, L.P.1,89%0,02 Mrd. USD
16Geode Capital Management, LLC1,88%0,02 Mrd. USD
17Algert Global LLC1,82%0,02 Mrd. USD
18D. E. Shaw & Co LP1,79%0,02 Mrd. USD
19Balyasny Asset Management LLC1,78%0,02 Mrd. USD
20Orbimed Advisors LLC1,61%0,02 Mrd. USD